Caspofungin Acetate NDC 0781-3421

NDC codes

FDA NDC Directory

Product NDC (as listed)0781-3421Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00781-3421Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0781-3421-94	00781342194	1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3421-94) / 10.8 mL in 1 VIAL, SINGLE-DOSE (0781-3421-01)Marketed from Sep 4, 2018

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caspofungin Acetate
Generic name (nonproprietary): caspofungin acetate
Active ingredients: Caspofungin acetate — 5 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200833
Marketing start: Sep 4, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Lipopeptides (Chemical structure)
Identifiers: Product ID 0781-3421_d70d52c0-6601-f632-e053-2995a90a9291SPL ID d70d52c0-6601-f632-e053-2995a90a9291SPL set ID 722facc6-d4ea-4975-b83e-3ae63df69ed2RxCUI 828539, 828755UNII VUW370O5QE
Pharmacologic class: Echinocandin Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400781342194 followed by a unit qualifier and the quantity

Package 00781-3421-94. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2022.

Indications (excerpt from the label)

Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for: Empirical therapy for presumed fungal infections in febrile, neutropenic patients. ( 1 ) Treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. ( 1 ) Treatment of esophageal candidiasis. ( 1 ) Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies. ( 1 ) 1.1 Empirical Therapy for Presumed Fungal Infections in Febrile, Neutropenic Patients Caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infecti…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200833

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200833
Product	Strength	Form · route	Labeler	Product NDC
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Sandoz Inc	0781-3423